Product Wiki · Recalls · Health Canada — Medical Devices

Becton Dickinson Information Technology Environment — recall 76515

Health Canada — Medical Devices · Canada · 2025-09-25 · Type II

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
Health Canada — Medical Devices
Recall identifier
76515
Date of alert
2025-09-25
Country / jurisdiction
Canada
Risk level
Type II
Risk type
recall
Product category
General hospital and personal use - Chemistry - Microbiology - Ophthalmology - Haematology
Product type
Medical devices
Reported risk: Through our cybersecurity monitoring tools and processes, BD recently identified unauthorized access to a limited portion of its information technology (IT) environment. BD terminated the unauthorized access and applied additional security measures. After a thorough investigation, BD confirmed that product service credentials intended for use by BD technical support teams for certain BD products were accessed by an unauthorized actor. Until these product service credentials are updated, there is a risk of unauthorized access that may impact the confidentiality, integrity and/or availability of the relevant products and associated system or data. To date, BD has not been made aware of any unauthorized use of these product service credentials and has received no reports of these credentials being used for unauthorized access to any BD device. Recall start date: October 31, 2024
Primary source: https://recalls-rappels.canada.ca/en/alert-recall/becton-dickinson-information-t

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

Related

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.